We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
-4.06%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$338M
AUM Growth
-$14.8M
(-4.2%)
Cap. Flow
+$1.69M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
27.46%
Holding
115
New
2
Increased
44
Reduced
22
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortrea Holdings
FTRE
|
+$662K |
| 2 |
ExxonMobil
XOM
|
+$348K |
| 3 |
Walt Disney
DIS
|
+$313K |
| 4 |
Verizon
VZ
|
+$284K |
| 5 |
Old Dominion Freight Line
ODFL
|
+$198K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$656K |
| 2 |
Microsoft
MSFT
|
+$496K |
| 3 |
Clorox
CLX
|
+$218K |
| 4 |
Apple
AAPL
|
+$128K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$86.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Healthcare | 13.58% |
| 3 | Consumer Staples | 11.22% |
| 4 | Industrials | 10.28% |
| 5 | Consumer Discretionary | 8.73% |
Similar funds
SCV
TFP
CWM
MG
HWMG
AI
LSWM
IMA
Boston Research & Management's Q3 2023 Portfolio in Review
As of Q3 2023, Boston Research & Management held 115 positions worth $338M, down 4.2% from $353M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 2.6%. Boston Research & Management opened 2 new positions and exited 1, leaving the 115-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.
- Boston Research & Management's largest Q3 2023 buy was Fortrea Holdings: 22,375 shares worth $639K.
- Boston Research & Management added most to ExxonMobil in Q3 2023, an estimated $348K increase.
- Boston Research & Management's biggest Q3 2023 reduction was Labcorp, cutting an estimated $656K.
- Boston Research & Management fully exited Clorox in Q3 2023, selling an estimated $218K.
- Boston Research & Management's ten largest holdings make up 27% of its $338M portfolio in Q3 2023.
- Boston Research & Management opened 2 new positions and closed 1 in Q3 2023.
- Boston Research & Management's portfolio value fell 4.2% quarter-over-quarter to $338M.
Based on Boston Research & Management's 13F filing for Q3 2023, filed 13 Nov 2023.